Prenatal Cardiology
en POLSKI
eISSN: 2449-6731
ISSN: 2449-6723
Prenatal Cardiology
Current issue Archive About the journal Editorial board Abstracting and indexing Contact Ethical standards and procedures Instructions for authors
Editorial System
Submit your Manuscript
1/2025
 
Share:
Share:
Review paper

History of prenatal cardiology in the world and in Poland

Łucja H. Biały
1
,
Maria Respondek-Liberska
1, 2

  1. Department of Prenatal Cardiology, Polish Mother’s Memorial Hospital Research Institute, Lodz, Poland
  2. Department of Fetal Malformations Diagnosis and Prevention, Medical University of Lodz, Poland
Prenat Cardio 2025
Online publish date: 2026/05/06
Article file
- History of prenatal.pdf  [0.13 MB]
Get citation
 
PlumX metrics:
 

The beginnings of fetal echocardiography


With the swift progress of technology after the Second World War and the consequent development of the first ultrasound machine, it was only a matter of time before it was used in fetal medicine. In 1958 Ian Donald revolutionised obstetric diagnostics by publishing in “Lancet” his work titled “Investigation of abdominal masses by pulsed ultrasound” [1]. It gave a starting point to the ongoing investigation of newer techniques. The earliest works done on fetal imaging included those done in 1972 by Stuart Campbell and in 1974 by Brian Trudinger, who described detection of major cardiac deformities and arrhythmias [2].
In the 1980s fetal cardiology became a reality. Advances made in ultrasound machine technology enabled fetal echocardiography examinations to be more precise and accurate, leading to an increased in prenatally detected congenital heart defects (CHD) [3]. Additionally, better imaging quality, evolving from M-mode into two-dimensional (2D) imaging and greater universality of ultrasound machines, led to the possibility of including structural cardiac screening in the fetal anatomy protocol, and at Guy’s Hospital in London, Lindsey Allan, Tony Tynan, et al. developed standardised protocols for cardiac screening with planes, the most important being the four-chamber view, which should be obtained in every examination [4, 5].
The works on prenatal cardiology were not limited to London. At the same time, in the USA, Kleinman et al. [6-9] were also describing fetal abnormalities with special interest in fetal arrhythmias and their treatment via the placenta. At this point in history, prenatal cardiology became an integral part of perinatal care, which involved numerous specialties, including obstetricians, paediatric cardiologists, neonatologists, surgeons, and radiologists.
Following the development of use of the Doppler effect and the invention of colour Doppler in the late 1980s and spectral Doppler in the early 1990s , the assessment of intracardiac, arterial, and venous flow patterns became a reality, leading to the possibility of evaluation of not only structures, but also functional abnormalities [10].
Moreover, Doppler cardiography also impacted the assessment of fetal well-being. Huhta et al. [11, 12] in 2005 developed the “Cardiovascular Profile Score” (CVPS) system, which described cardiovascular efficiency using flow patterns in the umbilical artery and vein, flow pattern in the ductus venosus, cardiac function (RV/LF shortening fraction, flow pattern through mitral and tricuspid valve – presence of a regurgitation, monophasic flow), presence of fetal hydrops (ascites, hydrothorax, or skin oedema), and heart size (using HA/CA measurement) [13, 14].
With further progress of the technology, the cardiac screening could be extended into the 1st trimester anatomy scan, done up to 13 + 6 weeks of gestation (Figure 1).

First-trimester fetal echocardiography examination


Initially, the first-trimester examination was only possible in our imagination, due to the difficulty of imaging such a small structure. The breakthrough happened in mid-1980s, when high-frequency transvaginal ultrasound probes were invented. Primarily, it was used to determine the existence of the fetal heartbeat in the 6-7th week of gestation, but it provided the basics for further studies [15].
From this point, researchers began to describe cardiac anatomy in early pregnancy fetuses from 11 + 0 to 13 + 6 weeks of gestation. The planes that could be assessed were the same ones as done earlier in a routine second-trimester scan, and at the beginning of the 1990s Gembruch et al. [16, 17] reported successful fetal heart assessment in 11-13 weeks of gestation. They were able to visualise the heart in four-chamber view and great-vessel view. Later, they also assessed not only the anatomical structure of the heart, but also its haemodynamics.
Afterwards, Nicolaides discovered that there is a correlation between nuchal translucency (NT) measured at 11-13 weeks of gestation and the occurrence of congenital heart defects in chromosomally abnormal fetuses [18].
Further progress led to cardiac evaluation by three-dimensional (3D), four-dimensional (4D), and spatiotemporal image correlation (STIC) [19], which improved the imaging quality. All the above resulted in the inclusion of fetal heart scanning in the International Society of Ultrasound in Obstetrics and Gynaecology (ISUOG) guidelines in 2006 [20, 21].
Guidelines were published not only from the ISUOG but also from other societies such as the American Heart Association (AHA) [22], the American Society of Echocardiography (ASE) [23], and the Association for European Paediatric Cardiology/Fetal Cardiology Working Group (AEPC/FCWG) [24].

Prenatal cardiology in Poland


In the late 20th century prenatal cardiology was also developing in Poland. The earliest articles were published in the 1980s and 1990s; however, systematic fetal cardiac assessment was not yet standard practice. In the 1990s Polish doctors started studying fetal echocardiography abroad and then implemented it into Polish standards. In 2004 Professors Maria Respondek-Liberska (trained in USA) and Joanna Szymkiewicz-Dangel (trained in the UK) initiated the Polish National Registry for Fetal Cardiac Pathology under the Ministry of Health [25, 26]. This unique data registry collected data nationwide on prenatally diagnosed CHD. As well as the registry, the cardio-prenatal program was implemented. Its aim was to simplify referral pathways and improve perinatal and neonatal cardiac care and to check how many fetal cardiac centres in Poland would have over 100 fetal cardiac defects per year (in the years 2004-2024 there were 4 such centres of so-called type C), based on their input into the registry. There is also a certification system; to gain certification, one must take part in a prenatal echocardiography workshop, one-week training in a Department of Prenatal Cardiology, and submit at least 10 abnormal cases with freeze-frames or cine-loops to the Polish National Registry for Fetal Cardiac Pathology – there are now 58 doctors with such certification in Poland. Later, in 2016, the Polish Prenatal Cardiology Society was established, and yearly fetal cardiac conferences have been organised in Łódź since 1997. In addition to the Polish Prenatal Society, there is the Fetal Cardiology Section of the Polish Ultrasound Society; there is also a group of obstetricians in the Polish Obstetrics and Gynaecology Society.
A fetus with accurate prenatal diagnosis can even be invasively treated prenatally in some rare, selected cases [27]. However, in most cases, prenatal cardiology is not only the diagnosis, but it is also used for the planning of future treatment. With the cooperation of the obstetrician, prenatal cardiologist, paediatric cardiologist, and cardiothoracic surgeon, the predicted outcome of newborns with CHD born with CHD has improved [28-30]. The prenatal diagnosis and accurate classification of the defect are crucial for the neonate’s outcome [30]. Neonates with adequate prenatal diagnosis can be treated soon after the birth, via cardiothoracic surgery, without delay. As an example, fetuses with HLHS can be named, because in recent years there has been an improvement in our tertiary centre in neonates surviving the Norwood procedure, nowadays reaching approximately 90% [31-33].
As time passes, there is still debate over who should perform the prenatal examination of the heart. There are a lot of arguments on both sides – whether it should be the obstetrician or paediatric cardiologist – but the answer is simple, it should be the person competent in fetal echocardiography, regardless of specialisation. In the future, it might evolve into a separate subspecialty, but for now we should encourage anyone with an inclination to perform such examination.
Nowadays, a rapid decline in the number of births in Poland can be observed. However, the number of congenital heart defects has remained at the same level. As the number of pregnancies acquired via IVF grows, the number of older women becoming pregnant increases, and the number of gravidas with other illnesses – such as pregestational diabetes – that are related to the origin of CHD, and consequently the number of fetuses requiring fetal echocardiography examination, also increases. Because fetal a echocardiography examination can predict some of the complications encountered in the neonatal period [34-36], recent recommendations of the Polish Prenatal Cardiology Association have become the first in the world recommend performing a fetal echocardiography examination not only in the 2nd trimester, but also in the 3rd [37].

Conclusions


The beginnings of prenatal cardiology are directly linked to the technological advances of the 20th century. From simple anatomical scanning, nowadays it includes complex perinatological care with the fetus recognised as a patient who can be diagnosed and treated. Fetal echocardiography is not restricted to the second-trimester scan but can be also carried out in the first trimester of pregnancy with great accuracy. It may also be carried out in the third trimester, opening a next new field of “prebirth cardiology”. The continued evolution of the field will depend on maintaining multidisciplinary cooperation and strengthening training in tertiary centres.

Disclosures


Ethical considerations: none.
This research received no external funding.
The authors declare no conflict of interest.

References

1. Donald I, Macvicar J, Brown TG. Investigation of abdominal masses by pulsed ultrasound. Lancet Lond Engl 1958; 1: 1188-1195.
2. Romero R. Giants in obstetrics and gynecology series: a profile of Stuart Campbell, DSc, FRCPEd, FRCOG, FACOG. Am J Obstet Gynecol 2020; 223: 152-166.
3. Allan LD, Crawford DC, Chita SK, Tynan MJ. Prenatal screening for congenital heart disease. BMJ 1986; 292: 1717-1719.
4. Allan LD, Tynan MJ, Campbell S, Wilkinson JL, Anderson RH. Echocardiographic and anatomical correlates in the fetus. Heart 1980; 44: 444-451.
5. Allan LD, Crawford DC, Anderson RH, Tynan MJ. Echocardiographic and anatomical correlations in fetal congenital heart disease. Heart 1984; 52: 542-548.
6. Kleinman CS, Hobbins JC, Jaffe CC, Lynch DC, Talner NS. Echocardiographic studies of the human fetus: prenatal diagnosis of congenital heart disease and cardiac dysrhythmias. Pediatrics 1980; 65: 1059-1067.
7. Kleinman CS, Donnerstein RL, Jaffe CC, et al. Fetal echocardiography. Am J Cardiol 1983; 51: 237-243.
8. Kleinman CS, Copel JA, Weinstein EM, Santulli TV, Hobbins JC. Treatment of fetal supraventricular tachyarrhythmias. J Clin Ultrasound 1985; 13: 265-273.
9. Kleinman CS, Copel JA, Weinstein EM, Santulli TV, Hobbins JC. In utero diagnosis and treatment of fetal supraventricular tachycardia. Semin Perinatol 1985; 9: 113-129.
10. Respondek-Liberska M, Kammermeier M, Ludomirsky A, Weil SR, Huhta JC. The prevalence and clinical significance of fetal tricuspid valve regurgitation with normal heart anatomy. Am J Obstet Gynecol 1994; 171: 1265-1270.
11. Huhta JC. Diagnosis and treatment of foetal heart failure: foetal echocardiography and foetal hydrops. Cardiol Young 2015; 25 (S2): 100-106.
12. Huhta JC. Fetal congestive heart failure. Semin Fetal Neonatal Med 2005; 10: 542-552.
13. Respondek-Liberska M, Lipiński M. Atlas wad serca u płodu: wybór patologii pod kątem ich znaczenia klinicznego [Atlas of prenatal heart defects: selected examples and their clinical significance]. Wydawnictwo ADI; 2011.
14. Respondek-Liberska M (red.). Kardiologia prenatalna: dla położników i kardiologów dziecięcych. Wydawnictwo Czelej, Lublin 2006.
15. Timor-Tritsch IE, Farine D, Rosen MG. A close look at early embryonic development with the high-frequency transvaginal transducer. Am J Obstet Gynecol 1988; 159: 676-681.
16. Gembruch U, Knöpfle G, Chatteriee M, Bald R, Redel DA, Födisch HJ, et al. Prenatal diagnosis of atrioventricular canal malformations with up-to-date echocardiographic technology: report of 14 cases. Am Heart J 1991; 121: 1489-1497.
17. Gembruch U, Knöpfle G, Bald R, Hansmann M. Early diagnosis of fetal congenital heart disease by transvaginal echocardiography. Ultrasound Obstet Gynecol 1993; 3: 310-317.
18. Nicolaides KH, Azar G, Snijders RJM, Gosden CM. Fetal nuchal oedema: associated malformations and chromosomal defects. Fetal Diagn Ther 1992; 7: 123-131.
19. Yagel S, Cohen SM, Shapiro I, Valsky DV. 3D and 4D ultrasound in fetal cardiac scanning: a new look at the fetal heart. Ultrasound Obstet Gynecol 2007; 29: 81-95.
20. Carvalho J, Allan L, Chaoui R, Copel JA, DeVore GR, Hecher K, et al.; International Society of Ultrasound in Obstetrics and Gynecology. ISUOG Practice Guidelines (updated): sonographic screening examination of the fetal heart. Ultrasound Obstet Gynecol 2013; 41: 348-359.
21. Cardiac screening examination of the fetus: guidelines for performing the “basic” and “extended basic” cardiac scan. Ultrasound Obstet Gynecol 2006; 27: 107-113.
22. Donofrio MT, Moon-Grady AJ, Hornberger LK, Copel JA, Sklansky MS, Abuhamad A, et al. Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association. Circulation 2014; 129: 2183-2242.
23. Moon-Grady AJ, Donofrio MT, Gelehrter S, Hornberger L, Kreeger J, Lee W, et al. Guidelines and recommendations for performance of the fetal echocardiogram: an update from the American Society of Echocardiography. J Am Soc Echocardiogr 2023; 36: 679-723.
24. Heying R, Albert DC, Voges I, Sendzikaite S, Sarquella-Brugada G, Pluchinotta F, et al. Association for European Paediatric and Congenital Cardiology recommendations for basic training in paediatric and congenital cardiology 2020. Cardiol Young 2020; 30: 1572-1587.
25. Respondek-Liberska M. Polish National Registry for Fetal Cardiac Malformations (www.orpkp.pl) and negative verifications during the 10 years. Prenat Cardiol 2015; 5: 4-11.
26. Kordjalik P, Radzymińska-Chruściel B, Słodki M. The Polish National Registry for Fetal Cardiac Pathology (www.orpkp.pl) – selected data analysis for 2013 and 2014 and comparison with data from 2004 to 2012. Prenat Cardio 2015; 5: 6-12.
27. Debska M, Kolesnik A, Rebizant B, Sekowska A, Grzyb A, Chaberek K, et al. Fetal cardiac interventions – Polish experience from “Zero” to the Third World Largest Program. J Clin Med 2020; 9: 2888.
28. Sylwestrzak O, Strzelecka I, Wójtowicz‐Marzec M, Krekora M, Moszura T, Słodki M, et al. Fetal echocardiography and early neonatal balloon valvuloplasty improved overall survival in prenatally detected aortic stenosis over 25 years of tertiary center experience. J Clin Ultrasound 2022; 50: 1279-1285.
29. Respondek-Liberska M, Sylwestrzak O, Slodki M, Strzelecka I. Fetal therapy guidelines – fetal echocardiography is of special value. Statement of the Polish Prenatal Cardiology Society. Ginekol Pol 2024; 95: 759-762.
30. Słodki M. Opracowanie modelu opieki nad ciężarną z wrodzoną wadą serca u płodu na podstawie nowego prenatalnego podziału wad serca. Państwowa Wyższa Szkoła Zawodowa w Płocku 2012.
31. Respondek-Liberska M, Strzelecka I, Slodki M, Krekora M, Grzesiak M, Gulczynska E, et al. Fetal hypoplastic left heart syndrome and neonatal follow-up in Polish Mother’s Memorial Hospital Research Institute report from January 2023 to January 2024: an improvement of survival rate. Ginekol Pol 2025; 96: 939-946.
32. Sokołowski Ł, Fendler W, Tobota Z, Kordjalik P, Krekora M, Słodkie M, et al. Detection screening and seasonality evaluation of hypoplastic left heart syndrome in the polish national registry for fetal cardiac anomalies from the years 2004 to 2016. Prenat Diagn 2020; 40: 698-704.
33. Sokolowski L, Respondek-Liberska M, Pietryga M, Slodki M. Prenatally diagnosed foramen ovale restriction in fetuses with hypoplastic left heart syndrome may be a predictor of longer hospitalization, but not of a need for an urgent rashkind procedure. Ginekol Pol 2019; 90: 31-38.
34. Biały ŁH, Sylwestrzak O, Murlewska J, Sokołowski Ł, Strzelecka I, Respondek-Liberska M. Prevalence of cardiovascular functional anomalies in large-for-gestational-age (LGA) fetuses by fetal echocardiography. J Clin Med 2025; 14: 4500.
35. Biały ŁH, Talar T, Gulczyńska E, Strzelecka I, Respondek-Liberska M. Prenatal diagnosis of ductal constriction in normal heart anatomy – are there any neonatal consequences? J Clin Med 2025; 14: 3388.
36. Respondek-Liberska M, Sylwestrzak O, Murlewska J, Biały Ł, Krekora M, Tadros-Zins M, et al. Fetal third-trimester functional cardiovascular abnormalities and neonatal elevated bilirubin level. J Clin Med 2023; 12: 6021.
37. Sokołowski Ł, Słodki M, Murlewska J, Strzelecka I, Kordjalik P, Blitek M, et al. Fetal echocardiography in the 3rd trimester of pregnancy as an essential element of modern prenatal diagnostics and perinatal care – recommendations of Polish Society of Prenatal Cardiology 2020. Prenat Cardio 2020; 10: 5-12.
This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Quick links
© 2026 Termedia Sp. z o.o.
Developed by Termedia.